Updated:
Inspira Technologies OXY B.H.N. Ltd
Inspira Technologies OXY B.H.N. Ltd is a medical technology company publicly listed with no publicly available founding year, office locations, or named...
Inspira Technologies OXY B.H.N. Ltd
Inspira Technologies OXY B.H.N. Ltd is a medical technology company publicly listed with no publicly available founding year, office locations, or named principals. The firm develops the INSPIRA ART100, an extracorporeal respiratory support system designed to replace invasive mechanical ventilation and enable patient recovery without sedation. No asset-class mix, portfolio companies, or co-investors have been disclosed in public records. The company's scale, team size, and any additional vehicles remain unknown. No structural differentiator beyond its core product pipeline has been identified.
General information
Firm type
Public Company
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
What does Inspira Technologies develop?
Inspira Technologies develops the INSPIRA ART100, an extracorporeal respiratory support system intended to offer a non-invasive alternative to mechanical ventilation.
Is Inspira Technologies a private or public company?
Inspira Technologies OXY B.H.N. Ltd is a publicly traded company.
What is the INSPIRA ART100?
The INSPIRA ART100 is a device that oxygenates blood outside the body without requiring invasive mechanical ventilation or sedation (per company filings).
Has Inspira Technologies disclosed any financial backers or AUM?
No. The firm has not publicly disclosed AUM, institutional backers, or family office involvement.
Where is Inspira Technologies headquartered?
The company's headquarters location is not disclosed in public records.
Who runs Inspira Technologies?
The company has not publicly named its principals or management team.
Does Inspira Technologies have any approved products?
The INSPIRA ART100 remains in development per company communications, with no disclosed regulatory approvals or commercial deployment as of mid-2025.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: